Medical Device / MedTech

Inner Logic Raises $11.5M for Procedural Device Infrastructure

Medical Product Outsourcing reports Inner Logic raised $11.5 million to build autonomy-enabling infrastructure for procedural devices.

By ROOK Industry News
Inner Logic funding announcement for autonomy-enabling procedural device infrastructure

Inner Logic, formerly Semaphor, has raised $11.5 million in a seed round co-led by General Catalyst and Bison Ventures, according to Medical Product Outsourcing.

The financing is tied to Inner Logic’s work on autonomy-enabling infrastructure for procedural devices. Medical Product Outsourcing identified the company’s prior name, Semaphor, in its report on the funding event.

Seed financing for procedural-device infrastructure

Medical Product Outsourcing reported that Inner Logic raised the seed funding to build autonomy-enabling infrastructure for procedural devices. The report places the company’s stated focus at the intersection of procedural devices and infrastructure intended to enable autonomy.

For medical-device sales professionals, the announcement identifies a newly funded company working in the procedural-device segment. The reported financing provides a defined event to follow as Inner Logic communicates further details about its infrastructure work.

The available report does not describe specific products, commercial agreements, customers, clinical use cases, or development timelines. It does, however, name the funding amount, round stage, lead investors, company rebrand, and stated infrastructure focus.

General Catalyst and Bison Ventures co-lead round

General Catalyst and Bison Ventures co-led the $11.5 million seed round, Medical Product Outsourcing reported. The publication named both firms in connection with Inner Logic’s financing.

The funding announcement also links the company’s former Semaphor identity with its current Inner Logic name. For professionals monitoring procedural technologies, the name change is relevant when following future company communications and references to the financing.

According to Medical Product Outsourcing, Inner Logic’s stated objective is to build autonomy-enabling infrastructure for procedural devices. The report does not provide additional details on the infrastructure’s design or deployment.

What the announcement establishes

  • Inner Logic, formerly Semaphor, raised $11.5 million.
  • The financing was a seed round.
  • General Catalyst and Bison Ventures co-led the round.
  • The company is building autonomy-enabling infrastructure for procedural devices.

The announcement centers on a financing event and the company’s stated procedural-device infrastructure focus, as reported by Medical Product Outsourcing.

Sources